Common cold or COVID-19? Some T cells are ready to combat both

Published on January 26, 2024

Scientists have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. The research promises to help scientists design and improve 'pan-coronavirus' vaccines that elicit broad, cross-protective responses.

Continue reading on website
Other news

Soap bark discovery offers a sustainability booster for the global vaccine market

January 26, 2024
A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for the first time, opening unprecedented opportunities for the vaccine industry.

DNA particles that mimic viruses hold promise as vaccines

January 30, 2024
Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.The vaccine, which has been tested in mice, consists of a DNA scaffold that carries many copies of a viral antigen. This type of vaccine, known as a particulate vaccine, mimics the structure of